Analystreport

DiaMedica Therapeutics Inc (NASDAQ: DMAC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

DiaMedica Therapeutics Inc.  (DMAC) 
Last diamedica therapeutics inc. earnings: 11/13 04:12 pm Check Earnings Report